Monoclonal antibodies which recognize an adenocarcinoma cell antigen
AssigneeThe General Hospital Corporation
InventorsJack R. Wands, Hiroshi Takahashi
Life of this patent
Estimating the term…
Abstract
The present invention is directed to antibodies, and fragments thereof, which specifically bind the AF-20 and the XF-8 epitopes of adenocarcinoma cell antigen(s).
Claims10
A monoclonal antibody, or F(ab) or F(ab).sub.2 fragment thereof, which specifically binds to an adenocarcinoma cell antigen AF-20, and which has the epitope binding specificity of an antibody produced by hybridoma cell line ATCC designation HB 9687.
A monoclonal antibody, or F(ab) or F(ab).sub.2 fragment thereof, which specifically binds to an adenocarcinoma cell antigen XF-8, and which has the epitope binding specificity of an antibody produced by hybridoma cell line ATCC designation HB 9686.
Dependencies are inferred from the claim text.